{"ticker": {"uuid": "0992398e-40b7-4989-8a5c-e7a04454c081", "symbol": "NOX", "name": "Noxopharm Limited", "exchange": "ASX", "country": "AU", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Noxopharm (ASX:NOX) Shares Ease as Investors Await Fresh Evidence From Its Biotechnology Pipeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxOb1A2NWNZd2Fwb0k5ckE0VHdTeDAwWG9RNzktREdEU1BPTU5hMUNfN3l0X0pndVlPSjVQdUJRdDIzWUJEVkRiR3hmNnc1NE9xeGx5RkxuVnZzNl9EbnpLY2RabklhUGhWc0JONWtwZEFSeURmVGFlUDRmMEZuS3pMR0x6QlBWRk5WM2wydjI5V0k0cmRCQlNJOF9GYkxuZDVfU3oxNUJ4ZnVjS3h1U0pUTklsbi02d0preS1WNGhQUlRndFhyWW0yMlFBcmVtdw?oc=5", "source_name": "Kalkine", "published_at": "2026-07-13T08:16:00+00:00", "published_display": "13 Jul 2026 08:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Has Noxopharm (ASX: NOX) Attracted Renewed Market Attention?", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxOc2lCelFnaG9kcnRiMGU5UWF2azV4X2RmSk9QUE1yZTZUbmxoNXh4b1AwckxHVFZEVFNCWXMtcGlxMkNLeEEwbGo1ZHY2emhZcmlDSEMwODhXREE0dHJ4c0dpNjM0YzlkV0NoMWhIOW16N1hfTGpGUXgzejY2X09XMEF4Z19sR3dOdlZkdVhTRUxpSWtpT3RabWdHWFhEWHp2?oc=5", "source_name": "Kalkine", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Noxopharm CEO discusses Sofra cancer platform | ASX:NOX", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxOTDZaY3NqaUtaNWQySzhHU1RhaXQ1VDlTUWZ4Q1dCZm14UkRFZ1EyTGtKQnNtLVhKNzROTlJqOFdORnh3Z3lOWU1lTFlZM3Y1LWFRa0ZkTFVYX01TUEdxaW81RTV6Z1ZVT1pGZXM2MUZVSVZnUnNiX01qYkVac1JlVWRMTE81RmEwMHJXQXdKakFjZGo2WnlDaXhNcXBwclI5cnJySWttZ1lSWjd2eXNZMw?oc=5", "source_name": "Proactive financial news", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Noxopharm (ASX:NOX) shares Skyrocket 40% Today- Here\u2019s Why?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxPQUtOYW41b21YbFRDZl95UGU2LS1fZTJQZ2lxb2h4RDk4MzZzZ2xQdnVld0djVEFRQkFjZFBpcmgwSzU3NlQtTHA1TmhBaXJ0NE1QUVRlWkYwVEdtNDVWeGNQWTJOQklza2dpMHF5aXhBVDJ3V3Q2T1h2aXRaVFk4QnowZzF1dmVzLVpXOTBseng2Y3RHb2c?oc=5", "source_name": "Kalkine", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Noxopharm (ASX:NOX) Moves Ahead with Key Biotechnology Initiative", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxPQy01OVo0aFZQQ3dSMlFubFp1dVZ6MDd0VGpTX1AxTW1aSW9NS25NdUhUb0JHaVJXb3lZTWRHa1ktZm5kT1d2b2hZMlp5a1lndTNyT1NyeFJSMDN5Ymp6T0oyeHRReG5SWlNxcE1OU3hTcTN3MmpjQ1ZiamJlakRYSHEtTnY2YnE5TThyM09LTl8wdGU5X2g3UjhlMmVuUC1yQl9N?oc=5", "source_name": "Kalkine", "published_at": "2026-05-20T07:00:00+00:00", "published_display": "20 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ASX All Ords Biotech: Is Noxopharm (ASX:NOX) in Focus?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNNV82emhyYU53bFpPaDlKVlFKZktvT2VKSmdCSURwYmk1UnZDbGFPbFNqOFA1U19YLWdHZ2I5SWZOTnA1UjctUFVRWm1zdXVTMXk4OHEwWWV4MmE0VGxRTV85X0tzbmc5ZTFfSjk3eDBEcERwVS1ZZzV6Z25iNnVKLU82UXM3dTNlc1RFcGpzMHJFLW1kSmhvQzdIbw?oc=5", "source_name": "Kalkine Media", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Noxopharm (ASX:NOX) Shares Hold Steady Despite Promising Sofra Lung Inflammation Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPZVlmemJMV25KMlVMUE1tOGY2UkVwblNXaEcwRFl5STNTVFNFRVpvQm52YzA4VE42Vzd0dmFEZXJQX3F0U2N2alNFa1daUnY2cGVmN0ZBWjJXQjItVVNaT2NUcE41XzM2LTJkRzJrZFJ5WjRXZklFV2RzQ2JwanBKakpRNnAwMFA1MXpvMnM2YjJKaXBpd1VNOEx3UlU5NDRuSUtPckZoUWZHaHlycUdsMVptUDQxc3BFRWQ4cXdrVXc4Zw?oc=5", "source_name": "Kalkine", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Noxopharm locks in up to $5m standby equity funding via Acuity ATM", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxQcnhTeWVVdW5LU1VRc0VneGtxR2lCQ05xcXBUYUtiY05weDh5NmlJaEtVMjhWRm1tVXlIOXNoYUs5di1RUzFCV0NKcW0tTFpza3M4dnVxMHctRkR4a09maDZXSE12Mmo3QzlVUjJXUlBMOVNrZHkycU9WSkw4NGFHM21icHc5d2xMUnN1cUNkUm42UWxYcGtDRVFhQlpHS042SlZTLXF0YllmbmF1dHVWd1NJdFkzeklVcE9LeEZzYWtydTgyT2lvbGlrdE9PSXFzLWdrRmln?oc=5", "source_name": "Proactive financial news", "published_at": "2026-02-27T08:00:00+00:00", "published_display": "27 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insights: Noxopharm Ltd (ASX:NOX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE4yV05xdXZ2amNmZXVFRHJaR0RHX0xxSlJod25OMjEyN09Yc1FzUkc4VzFzaG5nVDFaMWQ5dnZ3RmpPYjZBaF9UdmtyQ3gweG9t?oc=5", "source_name": "smallcaps.com.au", "published_at": "2025-10-30T15:18:47+00:00", "published_display": "30 Oct 2025 15:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "We're Keeping An Eye On Noxopharm's (ASX:NOX) Cash Burn Rate", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-07-29T07:00:00+00:00", "published_display": "29 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Just the Facts: Noxopharm", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNdk9QRGpWaTVvSFRQdnRRekxBOFlyNWhvYUhfSUFrcEpaOEUtSFZPNnNiWjMxVzRVZVJiYnFsTHYySFUwdVRUajMwWk1GSjNWRVp2RjV5MVNjZ2wzNm5KV0VmNzc3T0E3NlhlS0kzUmZGSkFXLU9yVUtpVWpwSnVKR3h6V0JmWXJYQktnS1ZmTUFKaml0NjhGbWNPM0x0cU0?oc=5", "source_name": "Proactive financial news", "published_at": "2024-08-19T07:00:00+00:00", "published_display": "19 Aug 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "mRNA is the next big thing in medicine. Here's why Noxopharm could be the ASX front runner in this field", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxQd1Z5eThWbWI4Q3A0UGYzZ2hpajlxendGTUNNblVJTWJrcTZqVXpvQzRmZVcwbEhuSk9kMlhGODFLX2pFckF0SFNucHFmWGZCRzF0SUV2VXMtcGlTR2tWRnc0a0c5aHdySWtlQmFJVmxkMlNudHdnWXNyM0dONW5uTU5oY19Oc0JMRjE5Yzljbi1mb25kYS1RbHN6S1dXSTYtWHR3bWtINzEtZmV6TUQ3a3paZ1ItRDJYRnNFNExvMTRVb3dfRVQwT2hlalR4LXZ2?oc=5", "source_name": "Stockhead", "published_at": "2023-11-01T07:00:00+00:00", "published_display": "01 Nov 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Noxopharm Ltd Share Price - NOX, RNS News, Articles, Quotes, & Charts (ASX:NOX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMia0FVX3lxTE1YMkR5YUNIQV9VOTNORzRfU01MamRKSG5FQklSUzlnMUlEYTBCdTdwbnF1dUpBRWZPTy14Wlk0NVNYRURfNFdyYXRkNVFnYnpqN1RqSHM4YUowamhJOFF2aC1HeFFpR2J6UU0w?oc=5", "source_name": "Proactive financial news", "published_at": "2021-04-12T15:27:26+00:00", "published_display": "12 Apr 2021 15:27", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Noxopharm Limited (ASX:NOX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMie0FVX3lxTFBTbHFreDNBaFNHWFZPckRFYXVtWlY3VUZlaHlQWi01bDk1VV8zZGVaS2ZxLXExT3cwU3R3RWxqRGtfZ3V5NWg3dHpZVGVUVE9Ha21wYVpDeE53a0c1NFItNjRVMlRKSk9QV05TN2ZVS3MtQ3QwWTRfZXBNVQ?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2019-09-27T03:15:52+00:00", "published_display": "27 Sep 2019 03:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NOX Stock Price and Chart \u2014 ASX:NOX", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTE0xWUJVdkd0VHBEYlN0andXUHJkM3FPS1BTcVc5eXV1NVhlM1JtYWNLakJ4bHFGdl92bl91QjBzS2J6T1JvREdPUmpTdmhxQ2E4X1BLbjFnQQ?oc=5", "source_name": "TradingView", "published_at": "2017-09-28T09:43:23+00:00", "published_display": "28 Sep 2017 09:43", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Noxopharm (ASX:NOX) Shares Ease as Investors Await Fresh Evidence From Its Biotechnology Pipeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxOb1A2NWNZd2Fwb0k5ckE0VHdTeDAwWG9RNzktREdEU1BPTU5hMUNfN3l0X0pndVlPSjVQdUJRdDIzWUJEVkRiR3hmNnc1NE9xeGx5RkxuVnZzNl9EbnpLY2RabklhUGhWc0JONWtwZEFSeURmVGFlUDRmMEZuS3pMR0x6QlBWRk5WM2wydjI5V0k0cmRCQlNJOF9GYkxuZDVfU3oxNUJ4ZnVjS3h1U0pUTklsbi02d0preS1WNGhQUlRndFhyWW0yMlFBcmVtdw?oc=5", "source_name": "Kalkine", "published_at": "2026-07-13T08:16:00+00:00", "published_display": "13 Jul 2026 08:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Has Noxopharm (ASX: NOX) Attracted Renewed Market Attention?", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxOc2lCelFnaG9kcnRiMGU5UWF2azV4X2RmSk9QUE1yZTZUbmxoNXh4b1AwckxHVFZEVFNCWXMtcGlxMkNLeEEwbGo1ZHY2emhZcmlDSEMwODhXREE0dHJ4c0dpNjM0YzlkV0NoMWhIOW16N1hfTGpGUXgzejY2X09XMEF4Z19sR3dOdlZkdVhTRUxpSWtpT3RabWdHWFhEWHp2?oc=5", "source_name": "Kalkine", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Noxopharm CEO discusses Sofra cancer platform | ASX:NOX", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxOTDZaY3NqaUtaNWQySzhHU1RhaXQ1VDlTUWZ4Q1dCZm14UkRFZ1EyTGtKQnNtLVhKNzROTlJqOFdORnh3Z3lOWU1lTFlZM3Y1LWFRa0ZkTFVYX01TUEdxaW81RTV6Z1ZVT1pGZXM2MUZVSVZnUnNiX01qYkVac1JlVWRMTE81RmEwMHJXQXdKakFjZGo2WnlDaXhNcXBwclI5cnJySWttZ1lSWjd2eXNZMw?oc=5", "source_name": "Proactive financial news", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Noxopharm (ASX:NOX) shares Skyrocket 40% Today- Here\u2019s Why?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxPQUtOYW41b21YbFRDZl95UGU2LS1fZTJQZ2lxb2h4RDk4MzZzZ2xQdnVld0djVEFRQkFjZFBpcmgwSzU3NlQtTHA1TmhBaXJ0NE1QUVRlWkYwVEdtNDVWeGNQWTJOQklza2dpMHF5aXhBVDJ3V3Q2T1h2aXRaVFk4QnowZzF1dmVzLVpXOTBseng2Y3RHb2c?oc=5", "source_name": "Kalkine", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Noxopharm (ASX:NOX) Moves Ahead with Key Biotechnology Initiative", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxPQy01OVo0aFZQQ3dSMlFubFp1dVZ6MDd0VGpTX1AxTW1aSW9NS25NdUhUb0JHaVJXb3lZTWRHa1ktZm5kT1d2b2hZMlp5a1lndTNyT1NyeFJSMDN5Ymp6T0oyeHRReG5SWlNxcE1OU3hTcTN3MmpjQ1ZiamJlakRYSHEtTnY2YnE5TThyM09LTl8wdGU5X2g3UjhlMmVuUC1yQl9N?oc=5", "source_name": "Kalkine", "published_at": "2026-05-20T07:00:00+00:00", "published_display": "20 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ASX All Ords Biotech: Is Noxopharm (ASX:NOX) in Focus?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNNV82emhyYU53bFpPaDlKVlFKZktvT2VKSmdCSURwYmk1UnZDbGFPbFNqOFA1U19YLWdHZ2I5SWZOTnA1UjctUFVRWm1zdXVTMXk4OHEwWWV4MmE0VGxRTV85X0tzbmc5ZTFfSjk3eDBEcERwVS1ZZzV6Z25iNnVKLU82UXM3dTNlc1RFcGpzMHJFLW1kSmhvQzdIbw?oc=5", "source_name": "Kalkine Media", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Noxopharm (ASX:NOX) Shares Hold Steady Despite Promising Sofra Lung Inflammation Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPZVlmemJMV25KMlVMUE1tOGY2UkVwblNXaEcwRFl5STNTVFNFRVpvQm52YzA4VE42Vzd0dmFEZXJQX3F0U2N2alNFa1daUnY2cGVmN0ZBWjJXQjItVVNaT2NUcE41XzM2LTJkRzJrZFJ5WjRXZklFV2RzQ2JwanBKakpRNnAwMFA1MXpvMnM2YjJKaXBpd1VNOEx3UlU5NDRuSUtPckZoUWZHaHlycUdsMVptUDQxc3BFRWQ4cXdrVXc4Zw?oc=5", "source_name": "Kalkine", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Noxopharm locks in up to $5m standby equity funding via Acuity ATM", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxQcnhTeWVVdW5LU1VRc0VneGtxR2lCQ05xcXBUYUtiY05weDh5NmlJaEtVMjhWRm1tVXlIOXNoYUs5di1RUzFCV0NKcW0tTFpza3M4dnVxMHctRkR4a09maDZXSE12Mmo3QzlVUjJXUlBMOVNrZHkycU9WSkw4NGFHM21icHc5d2xMUnN1cUNkUm42UWxYcGtDRVFhQlpHS042SlZTLXF0YllmbmF1dHVWd1NJdFkzeklVcE9LeEZzYWtydTgyT2lvbGlrdE9PSXFzLWdrRmln?oc=5", "source_name": "Proactive financial news", "published_at": "2026-02-27T08:00:00+00:00", "published_display": "27 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insights: Noxopharm Ltd (ASX:NOX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE4yV05xdXZ2amNmZXVFRHJaR0RHX0xxSlJod25OMjEyN09Yc1FzUkc4VzFzaG5nVDFaMWQ5dnZ3RmpPYjZBaF9UdmtyQ3gweG9t?oc=5", "source_name": "smallcaps.com.au", "published_at": "2025-10-30T15:18:47+00:00", "published_display": "30 Oct 2025 15:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "We're Keeping An Eye On Noxopharm's (ASX:NOX) Cash Burn Rate", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-07-29T07:00:00+00:00", "published_display": "29 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Just the Facts: Noxopharm", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNdk9QRGpWaTVvSFRQdnRRekxBOFlyNWhvYUhfSUFrcEpaOEUtSFZPNnNiWjMxVzRVZVJiYnFsTHYySFUwdVRUajMwWk1GSjNWRVp2RjV5MVNjZ2wzNm5KV0VmNzc3T0E3NlhlS0kzUmZGSkFXLU9yVUtpVWpwSnVKR3h6V0JmWXJYQktnS1ZmTUFKaml0NjhGbWNPM0x0cU0?oc=5", "source_name": "Proactive financial news", "published_at": "2024-08-19T07:00:00+00:00", "published_display": "19 Aug 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "mRNA is the next big thing in medicine. Here's why Noxopharm could be the ASX front runner in this field", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxQd1Z5eThWbWI4Q3A0UGYzZ2hpajlxendGTUNNblVJTWJrcTZqVXpvQzRmZVcwbEhuSk9kMlhGODFLX2pFckF0SFNucHFmWGZCRzF0SUV2VXMtcGlTR2tWRnc0a0c5aHdySWtlQmFJVmxkMlNudHdnWXNyM0dONW5uTU5oY19Oc0JMRjE5Yzljbi1mb25kYS1RbHN6S1dXSTYtWHR3bWtINzEtZmV6TUQ3a3paZ1ItRDJYRnNFNExvMTRVb3dfRVQwT2hlalR4LXZ2?oc=5", "source_name": "Stockhead", "published_at": "2023-11-01T07:00:00+00:00", "published_display": "01 Nov 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Noxopharm Ltd Share Price - NOX, RNS News, Articles, Quotes, & Charts (ASX:NOX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMia0FVX3lxTE1YMkR5YUNIQV9VOTNORzRfU01MamRKSG5FQklSUzlnMUlEYTBCdTdwbnF1dUpBRWZPTy14Wlk0NVNYRURfNFdyYXRkNVFnYnpqN1RqSHM4YUowamhJOFF2aC1HeFFpR2J6UU0w?oc=5", "source_name": "Proactive financial news", "published_at": "2021-04-12T15:27:26+00:00", "published_display": "12 Apr 2021 15:27", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Noxopharm Limited (ASX:NOX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMie0FVX3lxTFBTbHFreDNBaFNHWFZPckRFYXVtWlY3VUZlaHlQWi01bDk1VV8zZGVaS2ZxLXExT3cwU3R3RWxqRGtfZ3V5NWg3dHpZVGVUVE9Ha21wYVpDeE53a0c1NFItNjRVMlRKSk9QV05TN2ZVS3MtQ3QwWTRfZXBNVQ?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2019-09-27T03:15:52+00:00", "published_display": "27 Sep 2019 03:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NOX Stock Price and Chart \u2014 ASX:NOX", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTE0xWUJVdkd0VHBEYlN0andXUHJkM3FPS1BTcVc5eXV1NVhlM1JtYWNLakJ4bHFGdl92bl91QjBzS2J6T1JvREdPUmpTdmhxQ2E4X1BLbjFnQQ?oc=5", "source_name": "TradingView", "published_at": "2017-09-28T09:43:23+00:00", "published_display": "28 Sep 2017 09:43", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 81, "total_relevant": 15, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 15, "score": 50, "total": 15, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 90, "events": [{"event": "general", "label": "Market update", "weight": 7.15, "count": 13}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}, {"event": "liquidity", "label": "Balance sheet", "weight": 0.55, "count": 1}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 0.09, "latest_week": "2026-07-10", "one_week_move": -1.1, "four_week_move": 18.2, "twelve_week_move": 21.3, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 1.166776, "market_dynamics_buy_signal": false, "relative_strength": 7.240522, "fair_value_gap": 12.3, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "negative", "expectation_probability": 37.5961, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-1.1% over one week, +18.2% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 62, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Kalkine", "count": 5}, {"label": "Proactive financial news", "count": 4}, {"label": "Kalkine Media", "count": 1}, {"label": "smallcaps.com.au", "count": 1}, {"label": "simplywall.st", "count": 1}, {"label": "Stockhead", "count": 1}, {"label": "intelligentinvestor.com.au", "count": 1}, {"label": "TradingView", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 15}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 13}, {"label": "Earnings", "count": 1}, {"label": "Balance sheet", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "90/100 classification confidence."}, {"label": "Company focus", "value": "15", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-1.1% over one week, +18.2% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Noxopharm (ASX:NOX) Shares Ease as Investors Await Fresh Evidence From Its Biotechnology Pipeline"}], "updated_at": "2026-07-16T22:24:22.116551+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}